Since 2011, FAST has funded  $420,000.00 in Post Doctoral Fellowship Grants, over $1.25 million in FAST-Trac and Grant-In-Aid Grants, $180,000 on a human clinical trial on the Efficacy of Minocycline in the Treatment of Angelman Syndrome and more than $6.125 million to the  FAST Integrative Research Environment (FIRE) Initiative.

The FAST Integrative Research Environment (FIRE) Initiative has already identified 3 potential drug candidates and 2 gene therapy strategies for clinical trial and is creating 2 novel animal models. By end of 2016, FAST will have funded over $10.525 million in Angelman Syndrome research, bringing us ever-closer to a cure.

FAST’s grants and fellowship programs encourage research aimed at finding a treatment for Angelman Syndrome. Our expedited review process ensures funds are put into quality research as rapid as possible.

The Foundation for Angelman Syndrome Therapeutics UK (or FAST) is an organisation dedicated to finding a cure for Angelman Syndrome and related disorders through funding research, education and advocacy. FAST UK intends to support UK based research that will function collaboratively with our United States counterparts, aimed at finding a specific treatment for Angelman Syndrome.

FAST UK is committed to facilitating the establishment of primary investigators in the UK, while maintaining a strong collaborative relationship with AS investigators and the FAST Integrative Research Environment (FIRE) in the United States.

FAST UK operate, and are bound by a constitution that outlines our objectives:

• To facilitate research on the prevention, detection and treatment of Angelman Syndrome;
• Provide the findings of this research and other information on the Disease to sufferers, carers, the public and the medical community;
• To engage in activities to raise public awareness of the Disease and particularly the characteristics, diagnosis and treatment of the Disease;
• To encourage the commencement of research into the Disease in the UK;
• To liaise with other national and international organisations associated with research and advocacy; and
• To participate in national and international studies and research projects into the Disease.

Subscribe to our mailing list

* indicates required